LYSARC conducts its research in compliance with international quality standards: GCP, GLP, ICH.
It is ISO9001:2015 certified for the coordination and steering of LYSA / LYSARC clinical studies, in direct sponsoring or sponsoring delegation
It has in-house regulatory affairs, pharmacovigilance and quality assurance departments.
LYSARC is regularly audited by its partners and also audits study sites, its own services, its vendors, and validates the tools it uses for clinical research activities. All LYSARC staff receives training on quality assurance and internal regularly updated standard operating procedures.
All protocols and informed consent forms of trials performed by LYSARC undergo review by patients committees in the framework of a collaboration with the French Ligue Against Cancer.